NCT07477457 2026-03-17A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting45 enrolled